Logo for Climb Bio Inc

Climb Bio Investor Relations Material

Latest events

Logo for Climb Bio Inc

M&A Announcement

Climb Bio
Logo for Climb Bio

Q2 2024

14 Aug, 2024
Logo for Climb Bio

M&A Announcement

11 Apr, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Climb Bio Inc

Access all reports
Eliem Therapeutics, Inc. is a biotechnology company focused on developing therapies for neuronal excitability disorders, which are associated with conditions like chronic pain, epilepsy, depression, and anxiety. The company’s approach involves advancing clinical-stage compounds that target neurological diseases, aiming to address significant unmet medical needs. Eliem Therapeutics is headquartered in Wilmington, Delaware, and its shares are listed on the NASDAQ.